Antimicrobial Peptides Industry Research Report 2023

Antimicrobial Peptides Industry Research Report 2023


Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.

Highlights

The global Antimicrobial Peptides market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.
By region, North America had the highest share of sales, at about 35%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antimicrobial Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antimicrobial Peptides.
The Antimicrobial Peptides market size, estimations, and forecasts are provided in terms of sales volume (Mg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Antimicrobial Peptides market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antimicrobial Peptides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

AnaSpec
AMP Biotech
Phoenix Biotech
Novabiotics
Chinese Peptide
Ontores
GenScript
Hycult Biotech
Sunsmile
Ruixing Biotechnology
Zhongnong Yingtai Biotechnology
Glam Technology
ProteLight Pharmaceutical & Biotechnology

Product Type Insights

Global markets are presented by Antimicrobial Peptides type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Antimicrobial Peptides are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Antimicrobial Peptides segment by Type

Plant Antimicrobial Peptides
Microbial Antimicrobial Peptides
Animal Antimicrobial Peptides

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Antimicrobial Peptides market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Antimicrobial Peptides market.
Antimicrobial Peptides segment by Application

Pharmaceuticals
Feed Additives
Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Antimicrobial Peptides market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antimicrobial Peptides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Antimicrobial Peptides and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Antimicrobial Peptides industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antimicrobial Peptides.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Antimicrobial Peptides manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Antimicrobial Peptides by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Antimicrobial Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Frequently Asked Questions

Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Antimicrobial Peptides Market Size (2018-2029) & (US$ Million)
2.2.2 Global Antimicrobial Peptides Sales (2018-2029)
2.2.3 Global Antimicrobial Peptides Market Average Price (2018-2029)
2.3 Antimicrobial Peptides by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Plant Antimicrobial Peptides
1.2.3 Microbial Antimicrobial Peptides
1.2.4 Animal Antimicrobial Peptides
2.4 Antimicrobial Peptides by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Pharmaceuticals
2.4.3 Feed Additives
2.4.4 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Antimicrobial Peptides Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Antimicrobial Peptides Sales (Mg) of Manufacturers (2018-2023)
3.3 Global Antimicrobial Peptides Revenue of Manufacturers (2018-2023)
3.4 Global Antimicrobial Peptides Average Price by Manufacturers (2018-2023)
3.5 Global Antimicrobial Peptides Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Antimicrobial Peptides, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Antimicrobial Peptides, Product Type & Application
3.8 Global Manufacturers of Antimicrobial Peptides, Date of Enter into This Industry
3.9 Global Antimicrobial Peptides Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 AnaSpec
4.1.1 AnaSpec Company Information
4.1.2 AnaSpec Business Overview
4.1.3 AnaSpec Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
4.1.4 AnaSpec Antimicrobial Peptides Product Portfolio
4.1.5 AnaSpec Recent Developments
4.2 AMP Biotech
4.2.1 AMP Biotech Company Information
4.2.2 AMP Biotech Business Overview
4.2.3 AMP Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
4.2.4 AMP Biotech Antimicrobial Peptides Product Portfolio
4.2.5 AMP Biotech Recent Developments
4.3 Phoenix Biotech
4.3.1 Phoenix Biotech Company Information
4.3.2 Phoenix Biotech Business Overview
4.3.3 Phoenix Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Phoenix Biotech Antimicrobial Peptides Product Portfolio
4.3.5 Phoenix Biotech Recent Developments
4.4 Novabiotics
4.4.1 Novabiotics Company Information
4.4.2 Novabiotics Business Overview
4.4.3 Novabiotics Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Novabiotics Antimicrobial Peptides Product Portfolio
4.4.5 Novabiotics Recent Developments
4.5 Chinese Peptide
4.5.1 Chinese Peptide Company Information
4.5.2 Chinese Peptide Business Overview
4.5.3 Chinese Peptide Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Chinese Peptide Antimicrobial Peptides Product Portfolio
6.5.5 Chinese Peptide Recent Developments
4.6 Ontores
4.6.1 Ontores Company Information
4.6.2 Ontores Business Overview
4.6.3 Ontores Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Ontores Antimicrobial Peptides Product Portfolio
4.6.5 Ontores Recent Developments
4.7 GenScript
4.7.1 GenScript Company Information
4.7.2 GenScript Business Overview
4.7.3 GenScript Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
4.7.4 GenScript Antimicrobial Peptides Product Portfolio
4.7.5 GenScript Recent Developments
6.8 Hycult Biotech
4.8.1 Hycult Biotech Company Information
4.8.2 Hycult Biotech Business Overview
4.8.3 Hycult Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Hycult Biotech Antimicrobial Peptides Product Portfolio
4.8.5 Hycult Biotech Recent Developments
4.9 Sunsmile
4.9.1 Sunsmile Company Information
4.9.2 Sunsmile Business Overview
4.9.3 Sunsmile Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Sunsmile Antimicrobial Peptides Product Portfolio
4.9.5 Sunsmile Recent Developments
4.10 Ruixing Biotechnology
4.10.1 Ruixing Biotechnology Company Information
4.10.2 Ruixing Biotechnology Business Overview
4.10.3 Ruixing Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Ruixing Biotechnology Antimicrobial Peptides Product Portfolio
4.10.5 Ruixing Biotechnology Recent Developments
6.11 Zhongnong Yingtai Biotechnology
6.11.1 Zhongnong Yingtai Biotechnology Company Information
6.11.2 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Business Overview
6.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Portfolio
6.11.5 Zhongnong Yingtai Biotechnology Recent Developments
6.12 Glam Technology
6.12.1 Glam Technology Company Information
6.12.2 Glam Technology Antimicrobial Peptides Business Overview
6.12.3 Glam Technology Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Glam Technology Antimicrobial Peptides Product Portfolio
6.12.5 Glam Technology Recent Developments
6.13 ProteLight Pharmaceutical & Biotechnology
6.13.1 ProteLight Pharmaceutical & Biotechnology Company Information
6.13.2 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Business Overview
6.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
6.13.4 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Portfolio
6.13.5 ProteLight Pharmaceutical & Biotechnology Recent Developments
5 Global Antimicrobial Peptides Market Scenario by Region
5.1 Global Antimicrobial Peptides Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Antimicrobial Peptides Sales by Region: 2018-2029
5.2.1 Global Antimicrobial Peptides Sales by Region: 2018-2023
5.2.2 Global Antimicrobial Peptides Sales by Region: 2024-2029
5.3 Global Antimicrobial Peptides Revenue by Region: 2018-2029
5.3.1 Global Antimicrobial Peptides Revenue by Region: 2018-2023
5.3.2 Global Antimicrobial Peptides Revenue by Region: 2024-2029
5.4 North America Antimicrobial Peptides Market Facts & Figures by Country
5.4.1 North America Antimicrobial Peptides Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Antimicrobial Peptides Sales by Country (2018-2029)
5.4.3 North America Antimicrobial Peptides Revenue by Country (2018-2029)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Antimicrobial Peptides Market Facts & Figures by Country
5.5.1 Europe Antimicrobial Peptides Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Antimicrobial Peptides Sales by Country (2018-2029)
5.5.3 Europe Antimicrobial Peptides Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Antimicrobial Peptides Market Facts & Figures by Country
5.6.1 Asia Pacific Antimicrobial Peptides Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Antimicrobial Peptides Sales by Country (2018-2029)
5.6.3 Asia Pacific Antimicrobial Peptides Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Antimicrobial Peptides Market Facts & Figures by Country
5.7.1 Latin America Antimicrobial Peptides Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Antimicrobial Peptides Sales by Country (2018-2029)
5.7.3 Latin America Antimicrobial Peptides Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Antimicrobial Peptides Market Facts & Figures by Country
5.8.1 Middle East and Africa Antimicrobial Peptides Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Antimicrobial Peptides Sales by Country (2018-2029)
5.8.3 Middle East and Africa Antimicrobial Peptides Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Antimicrobial Peptides Sales by Type (2018-2029)
6.1.1 Global Antimicrobial Peptides Sales by Type (2018-2029) & (Mg)
6.1.2 Global Antimicrobial Peptides Sales Market Share by Type (2018-2029)
6.2 Global Antimicrobial Peptides Revenue by Type (2018-2029)
6.2.1 Global Antimicrobial Peptides Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Antimicrobial Peptides Revenue Market Share by Type (2018-2029)
6.3 Global Antimicrobial Peptides Price by Type (2018-2029)
7 Segment by Application
7.1 Global Antimicrobial Peptides Sales by Application (2018-2029)
7.1.1 Global Antimicrobial Peptides Sales by Application (2018-2029) & (Mg)
7.1.2 Global Antimicrobial Peptides Sales Market Share by Application (2018-2029)
7.2 Global Antimicrobial Peptides Revenue by Application (2018-2029)
6.2.1 Global Antimicrobial Peptides Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Antimicrobial Peptides Revenue Market Share by Application (2018-2029)
7.3 Global Antimicrobial Peptides Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Antimicrobial Peptides Value Chain Analysis
8.1.1 Antimicrobial Peptides Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Antimicrobial Peptides Production Mode & Process
8.2 Antimicrobial Peptides Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Antimicrobial Peptides Distributors
8.2.3 Antimicrobial Peptides Customers
9 Global Antimicrobial Peptides Analyzing Market Dynamics
9.1 Antimicrobial Peptides Industry Trends
9.2 Antimicrobial Peptides Industry Drivers
9.3 Antimicrobial Peptides Industry Opportunities and Challenges
9.4 Antimicrobial Peptides Industry Restraints
10 Report Conclusion
11 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Antimicrobial Peptides Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Antimicrobial Peptides Sales (Mg) of Manufacturers (2018-2023)
Table 7. Global Antimicrobial Peptides Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Antimicrobial Peptides Revenue of Manufacturers (2018-2023)
Table 9. Global Antimicrobial Peptides Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Antimicrobial Peptides Average Price (US$/Mg) of Manufacturers (2018-2023)
Table 11. Global Antimicrobial Peptides Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Antimicrobial Peptides, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antimicrobial Peptides by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. AnaSpec Company Information
Table 17. AnaSpec Business Overview
Table 18. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2018-2023)
Table 19. AnaSpec Antimicrobial Peptides Product Portfolio
Table 20. AnaSpec Recent Developments
Table 21. AMP Biotech Company Information
Table 22. AMP Biotech Business Overview
Table 23. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2018-2023)
Table 24. AMP Biotech Antimicrobial Peptides Product Portfolio
Table 25. AMP Biotech Recent Developments
Table 26. Phoenix Biotech Company Information
Table 27. Phoenix Biotech Business Overview
Table 28. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2018-2023)
Table 29. Phoenix Biotech Antimicrobial Peptides Product Portfolio
Table 30. Phoenix Biotech Recent Developments
Table 31. Novabiotics Company Information
Table 32. Novabiotics Business Overview
Table 33. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2018-2023)
Table 34. Novabiotics Antimicrobial Peptides Product Portfolio
Table 35. Novabiotics Recent Developments
Table 36. Chinese Peptide Company Information
Table 37. Chinese Peptide Business Overview
Table 38. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2018-2023)
Table 39. Chinese Peptide Antimicrobial Peptides Product Portfolio
Table 40. Chinese Peptide Recent Developments
Table 41. Ontores Company Information
Table 42. Ontores Business Overview
Table 43. Ontores Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2018-2023)
Table 44. Ontores Antimicrobial Peptides Product Portfolio
Table 45. Ontores Recent Developments
Table 46. GenScript Company Information
Table 47. GenScript Business Overview
Table 48. GenScript Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2018-2023)
Table 49. GenScript Antimicrobial Peptides Product Portfolio
Table 50. GenScript Recent Developments
Table 51. Hycult Biotech Company Information
Table 52. Hycult Biotech Business Overview
Table 53. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2018-2023)
Table 54. Hycult Biotech Antimicrobial Peptides Product Portfolio
Table 55. Hycult Biotech Recent Developments
Table 56. Sunsmile Company Information
Table 57. Sunsmile Business Overview
Table 58. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2018-2023)
Table 59. Sunsmile Antimicrobial Peptides Product Portfolio
Table 60. Sunsmile Recent Developments
Table 61. Ruixing Biotechnology Company Information
Table 62. Ruixing Biotechnology Business Overview
Table 63. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2018-2023)
Table 64. Ruixing Biotechnology Antimicrobial Peptides Product Portfolio
Table 65. Ruixing Biotechnology Recent Developments
Table 66. Zhongnong Yingtai Biotechnology Company Information
Table 67. Zhongnong Yingtai Biotechnology Business Overview
Table 68. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2018-2023)
Table 69. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Portfolio
Table 70. Zhongnong Yingtai Biotechnology Recent Developments
Table 71. Glam Technology Company Information
Table 72. Glam Technology Business Overview
Table 73. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2018-2023)
Table 74. Glam Technology Antimicrobial Peptides Product Portfolio
Table 75. Glam Technology Recent Developments
Table 76. ProteLight Pharmaceutical & Biotechnology Company Information
Table 77. ProteLight Pharmaceutical & Biotechnology Business Overview
Table 78. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2018-2023)
Table 79. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Portfolio
Table 80. ProteLight Pharmaceutical & Biotechnology Recent Developments
Table 81. Global Antimicrobial Peptides Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 82. Global Antimicrobial Peptides Sales by Region (2018-2023) & (Mg)
Table 83. Global Antimicrobial Peptides Sales Market Share by Region (2018-2023)
Table 84. Global Antimicrobial Peptides Sales by Region (2024-2029) & (Mg)
Table 85. Global Antimicrobial Peptides Sales Market Share by Region (2024-2029)
Table 86. Global Antimicrobial Peptides Revenue by Region (2018-2023) & (US$ Million)
Table 87. Global Antimicrobial Peptides Revenue Market Share by Region (2018-2023)
Table 88. Global Antimicrobial Peptides Revenue by Region (2024-2029) & (US$ Million)
Table 89. Global Antimicrobial Peptides Revenue Market Share by Region (2024-2029)
Table 90. North America Antimicrobial Peptides Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. North America Antimicrobial Peptides Sales by Country (2018-2023) & (Mg)
Table 92. North America Antimicrobial Peptides Sales by Country (2024-2029) & (Mg)
Table 93. North America Antimicrobial Peptides Revenue by Country (2018-2023) & (US$ Million)
Table 94. North America Antimicrobial Peptides Revenue by Country (2024-2029) & (US$ Million)
Table 95. Europe Antimicrobial Peptides Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. Europe Antimicrobial Peptides Sales by Country (2018-2023) & (Mg)
Table 97. Europe Antimicrobial Peptides Sales by Country (2024-2029) & (Mg)
Table 98. Europe Antimicrobial Peptides Revenue by Country (2018-2023) & (US$ Million)
Table 99. Europe Antimicrobial Peptides Revenue by Country (2024-2029) & (US$ Million)
Table 100. Asia Pacific Antimicrobial Peptides Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. Asia Pacific Antimicrobial Peptides Sales by Country (2018-2023) & (Mg)
Table 102. Asia Pacific Antimicrobial Peptides Sales by Country (2024-2029) & (Mg)
Table 103. Asia Pacific Antimicrobial Peptides Revenue by Country (2018-2023) & (US$ Million)
Table 104. Asia Pacific Antimicrobial Peptides Revenue by Country (2024-2029) & (US$ Million)
Table 105. Latin America Antimicrobial Peptides Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Latin America Antimicrobial Peptides Sales by Country (2018-2023) & (Mg)
Table 107. Latin America Antimicrobial Peptides Sales by Country (2024-2029) & (Mg)
Table 108. Latin America Antimicrobial Peptides Revenue by Country (2018-2023) & (US$ Million)
Table 109. Latin America Antimicrobial Peptides Revenue by Country (2024-2029) & (US$ Million)
Table 110. Middle East and Africa Antimicrobial Peptides Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Middle East and Africa Antimicrobial Peptides Sales by Country (2018-2023) & (Mg)
Table 112. Middle East and Africa Antimicrobial Peptides Sales by Country (2024-2029) & (Mg)
Table 113. Middle East and Africa Antimicrobial Peptides Revenue by Country (2018-2023) & (US$ Million)
Table 114. Middle East and Africa Antimicrobial Peptides Revenue by Country (2024-2029) & (US$ Million)
Table 115. Global Antimicrobial Peptides Sales by Type (2018-2023) & (Mg)
Table 116. Global Antimicrobial Peptides Sales by Type (2024-2029) & (Mg)
Table 117. Global Antimicrobial Peptides Sales Market Share by Type (2018-2023)
Table 118. Global Antimicrobial Peptides Sales Market Share by Type (2024-2029)
Table 119. Global Antimicrobial Peptides Revenue by Type (2018-2023) & (US$ Million)
Table 120. Global Antimicrobial Peptides Revenue by Type (2024-2029) & (US$ Million)
Table 121. Global Antimicrobial Peptides Revenue Market Share by Type (2018-2023)
Table 122. Global Antimicrobial Peptides Revenue Market Share by Type (2024-2029)
Table 123. Global Antimicrobial Peptides Price by Type (2018-2023) & (US$/Mg)
Table 124. Global Antimicrobial Peptides Price by Type (2024-2029) & (US$/Mg)
Table 125. Global Antimicrobial Peptides Sales by Application (2018-2023) & (Mg)
Table 126. Global Antimicrobial Peptides Sales by Application (2024-2029) & (Mg)
Table 127. Global Antimicrobial Peptides Sales Market Share by Application (2018-2023)
Table 128. Global Antimicrobial Peptides Sales Market Share by Application (2024-2029)
Table 129. Global Antimicrobial Peptides Revenue by Application (2018-2023) & (US$ Million)
Table 130. Global Antimicrobial Peptides Revenue by Application (2024-2029) & (US$ Million)
Table 131. Global Antimicrobial Peptides Revenue Market Share by Application (2018-2023)
Table 132. Global Antimicrobial Peptides Revenue Market Share by Application (2024-2029)
Table 133. Global Antimicrobial Peptides Price by Application (2018-2023) & (US$/Mg)
Table 134. Global Antimicrobial Peptides Price by Application (2024-2029) & (US$/Mg)
Table 135. Key Raw Materials
Table 136. Raw Materials Key Suppliers
Table 137. Antimicrobial Peptides Distributors List
Table 138. Antimicrobial Peptides Customers List
Table 139. Antimicrobial Peptides Industry Trends
Table 140. Antimicrobial Peptides Industry Drivers
Table 141. Antimicrobial Peptides Industry Restraints
Table 142. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Antimicrobial PeptidesProduct Picture
Figure 5. Global Antimicrobial Peptides Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Antimicrobial Peptides Market Size (2018-2029) & (US$ Million)
Figure 7. Global Antimicrobial Peptides Sales (2018-2029) & (Mg)
Figure 8. Global Antimicrobial Peptides Average Price (US$/Mg) & (2018-2029)
Figure 9. Plant Antimicrobial Peptides Product Picture
Figure 10. Microbial Antimicrobial Peptides Product Picture
Figure 11. Animal Antimicrobial Peptides Product Picture
Figure 12. Pharmaceuticals Product Picture
Figure 13. Feed Additives Product Picture
Figure 14. Others Product Picture
Figure 15. Global Antimicrobial Peptides Revenue Share by Manufacturers in 2022
Figure 16. Global Manufacturers of Antimicrobial Peptides, Manufacturing Sites & Headquarters
Figure 17. Global Manufacturers of Antimicrobial Peptides, Date of Enter into This Industry
Figure 18. Global Top 5 and 10 Antimicrobial Peptides Players Market Share by Revenue in 2022
Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 20. Global Antimicrobial Peptides Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. Global Antimicrobial Peptides Sales by Region in 2022
Figure 22. Global Antimicrobial Peptides Revenue by Region in 2022
Figure 23. North America Antimicrobial Peptides Market Size by Country in 2022
Figure 24. North America Antimicrobial Peptides Sales Market Share by Country (2018-2029)
Figure 25. North America Antimicrobial Peptides Revenue Market Share by Country (2018-2029)
Figure 26. U.S. Antimicrobial Peptides Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Antimicrobial Peptides Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Antimicrobial Peptides Market Size by Country in 2022
Figure 29. Europe Antimicrobial Peptides Sales Market Share by Country (2018-2029)
Figure 30. Europe Antimicrobial Peptides Revenue Market Share by Country (2018-2029)
Figure 31. Germany Antimicrobial Peptides Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. France Antimicrobial Peptides Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. U.K. Antimicrobial Peptides Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Italy Antimicrobial Peptides Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Russia Antimicrobial Peptides Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Asia Pacific Antimicrobial Peptides Market Size by Country in 2022
Figure 37. Asia Pacific Antimicrobial Peptides Sales Market Share by Country (2018-2029)
Figure 38. Asia Pacific Antimicrobial Peptides Revenue Market Share by Country (2018-2029)
Figure 39. China Antimicrobial Peptides Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Japan Antimicrobial Peptides Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. South Korea Antimicrobial Peptides Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. India Antimicrobial Peptides Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Australia Antimicrobial Peptides Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. China Taiwan Antimicrobial Peptides Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Indonesia Antimicrobial Peptides Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Thailand Antimicrobial Peptides Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Malaysia Antimicrobial Peptides Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Latin America Antimicrobial Peptides Market Size by Country in 2022
Figure 49. Latin America Antimicrobial Peptides Sales Market Share by Country (2018-2029)
Figure 50. Latin America Antimicrobial Peptides Revenue Market Share by Country (2018-2029)
Figure 51. Mexico Antimicrobial Peptides Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Brazil Antimicrobial Peptides Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Argentina Antimicrobial Peptides Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Middle East and Africa Antimicrobial Peptides Market Size by Country in 2022
Figure 55. Middle East and Africa Antimicrobial Peptides Sales Market Share by Country (2018-2029)
Figure 56. Middle East and Africa Antimicrobial Peptides Revenue Market Share by Country (2018-2029)
Figure 57. Turkey Antimicrobial Peptides Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Saudi Arabia Antimicrobial Peptides Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. UAE Antimicrobial Peptides Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. Global Antimicrobial Peptides Sales Market Share by Type (2018-2029)
Figure 61. Global Antimicrobial Peptides Revenue Market Share by Type (2018-2029)
Figure 62. Global Antimicrobial Peptides Price (US$/Mg) by Type (2018-2029)
Figure 63. Global Antimicrobial Peptides Sales Market Share by Application (2018-2029)
Figure 64. Global Antimicrobial Peptides Revenue Market Share by Application (2018-2029)
Figure 65. Global Antimicrobial Peptides Price (US$/Mg) by Application (2018-2029)
Figure 66. Antimicrobial Peptides Value Chain
Figure 67. Antimicrobial Peptides Production Mode & Process
Figure 68. Direct Comparison with Distribution Share
Figure 69. Distributors Profiles
Figure 70. Antimicrobial Peptides Industry Opportunities and Challenges

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings